Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. IVA.NASDAQ

Inventiva Sa (IVA NASDAQ) stock market data APIs

$2.41 0.13(5.7%) as of July 26, 2024
Price chart is built with Anychart

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.

Inventiva Sa Financial Data Overview

2.28
2.41
-
2.48
2.2001
2.15-4.75
132 M
52 362 K
23 163 K
0
1.048
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'IVA',
Type: 'Common Stock',
Name: 'Inventiva Sa',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00VM4C335',
ISIN: NULL,
CUSIP: NULL,
CIK: '1756594',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2020-07-10',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'ADR',
IsDelisted: false,
}

Inventiva Sa Fundamental Data is available in our Financial Data APIs

  • Net Revenue 23 163 K
  • EBITDA -101 848 000
  • Earnings Per Share -2.64
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Inventiva Sa Earnings via APIs

  • Latest Release 2024-05-21
  • EPS/Forecast -0.47

Get Inventiva Sa End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Inventiva Sa latest news via APIs

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

INVENTIVA Daix (France), Long Island City (New York, United States), January 24, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company fo...

Inventiva draws down the second tranche of €25 million under existing Finance Contract with the European Investment Bank

INVENTIVA Inventiva intends to use the proceeds to fund part of its ongoing pivotal NATiV3 Phase III clinical trial evaluating lanifibranor in patients with NASH. This second tranche carries an inter...
Do you have any questions?
support@eodhistoricaldata.com